Table 1.
|
All cases |
Surgical cases |
---|---|---|
Variable | (n = 94) | (n = 30) |
Age (y), mean (range) |
61.6 (31.1, 90.1) |
65.2 (36.3, 89.7) |
Gender (M:F) |
70:24 |
17:13 |
Primary |
|
|
Oral Cavity |
24 (25.5%) |
19 (63.3%) |
Oropharynx |
22 (23.4%) |
2 (6.7%) |
Hypopharynx |
2 (2.1%) |
0 (0.0%) |
Larynx |
15 (16.0%) |
3 (10.0%) |
Salivary Gland |
6 (6.4%) |
3 (10.0%) |
NC & PNS |
5 (5.3%) |
2 (6.7%) |
Nasopharynx |
7 (7.4%) |
0 (0.0%) |
Thyroid |
1 (1.1%) |
0 (0.0%) |
Unknown |
5 (5.3%) |
0 (0.0%) |
Skin |
4 (4.3%) |
1 (3.3%) |
Lymphoma |
3 (3.2%) |
0 (0.0%) |
Stage |
|
|
Benign |
2 (2.1%) |
1 (3.3%) |
Stage 0 |
3 (3.2%) |
2 (6.7%) |
Stage I |
9 (9.6%) |
4 (13.3%) |
Stage II |
3 (3.2%) |
2 (6.7%) |
Stage III |
9 (9.6%) |
3 (10.0%) |
Stage IV | 68 (72.3%) | 18 (60.0%) |
NC & PNS, Nasal Cavity and Paranasal Sinuses.